BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · Registration

RARE ACCESS ACTION PROJECT

via MJS ADVISORS LLC

2nd Quarter (Apr 1 - June 30) · 2023Posted Jul 24, 2023Filing document ↗LDA record ↗

Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.

Client

Name: RARE ACCESS ACTION PROJECT
Description: Rare Disease Policy and Advocacy
Location: District of Columbia · United States of America

Registrant

Firm: MJS ADVISORS LLC
Location: Mesa, Arizona, United States of America

Lobbying activities

2 issues

Budget/Appropriations
Advice and counsel related to funding for matters related to rare disease research and treatment
LobbyistsMATTHEW SALMON
Medicare/Medicaid
Advice and counsel related to funding for matters related to rare disease research and treatment
LobbyistsMATTHEW SALMON

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

RARE ACCESS ACTION PROJECT — Lobbying — Receipts Report